Published online 28 July 2005
Article |
Preferential binding of a G-quadruplex ligand to human chromosome ends
1LRP, DRR, CEA 92265 Fontenay-aux-Roses, France 2Laboratoire de Biophysique, INSERM U565, CNRS UMR 5153, Muséum National d'Histoire Naturelle USM 503 75005 Paris, France 3Aventis Pharma SA, Centre de Recherche de Paris 94403 Vitry-sur-Seine, France 4Laboratoire d'Onco-Pharmacologie, JE 2428, Université de Reims Champagne-Ardenne 51096, Reims, France
*To whom correspondance should be addressed. Tel: +33 1 46 54 97 91; Fax: +33 1 46 54 97 02; Email: boussin{at}cea.fr
Received April 19, 2005. Revised June 17, 2005. Accepted July 5, 2005.
The G-overhangs of telomeres are thought to adopt particular conformations, such as T-loops or G-quadruplexes. It has been suggested that G-quadruplex structures could be stabilized by specific ligands in a new approach to cancer treatment consisting in inhibition of telomerase, an enzyme involved in telomere maintenance and cell immortality. Although the formation of G-quadruplexes was demonstrated in vitro many years ago, it has not been definitively demonstrated in living human cells. We therefore investigated the chromosomal binding of a tritiated G-quadruplex ligand, 3H-360A (2,6-N,N'-methyl-quinolinio-3-yl)-pyridine dicarboxamide [methyl-3H]. We verified the in vitro selectivity of 3H-360A for G-quadruplex structures by equilibrium dialysis. We then showed by binding experiments with human genomic DNA that 3H-360A has a very potent selectivity toward G-quadruplex structures of the telomeric 3'-overhang. Finally, we performed autoradiography of metaphase spreads from cells cultured with 3H-360A. We found that 3H-360A was preferentially bound to chromosome terminal regions of both human normal (peripheral blood lymphocytes) and tumor cells (T98G and CEM1301). In conclusion, our results provide evidence that a specific G-quadruplex ligand interacts with the terminal ends of human chromosomes. They support the hypothesis that G-quadruplex ligands induce and/or stabilize G-quadruplex structures at telomeres of human cells.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Arora, M. Dutkiewicz, V. Scaria, M. Hariharan, S. Maiti, and J. Kurreck Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif RNA, July 1, 2008; 14(7): 1290 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tang, Z.-y. Kan, Y. Yao, Q. Wang, Y.-h. Hao, and Z. Tan G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA Nucleic Acids Res., March 27, 2008; 36(4): 1200 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pennarun, C. Granotier, F. Hoffschir, E. Mandine, D. Biard, L. R. Gauthier, and F. D. Boussin Role of ATM in the telomere response to the G-quadruplex ligand 360A Nucleic Acids Res., March 1, 2008; 36(5): 1741 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-y. Kan, Y. Lin, F. Wang, X.-y. Zhuang, Y. Zhao, D.-w. Pang, Y.-h. Hao, and Z. Tan G-quadruplex formation in human telomeric (TTAGGG)4 sequence with complementary strand in close vicinity under molecularly crowded condition Nucleic Acids Res., June 28, 2007; 35(11): 3646 - 3653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Cian and J.-L. Mergny Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation Nucleic Acids Res., April 3, 2007; 35(8): 2483 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qi, C.-P. Lin, X. Fu, L. M. Wood, A. A. Liu, Y.-C. Tsai, Y. Chen, C. M. Barbieri, D. S. Pilch, and L. F. Liu G-Quadruplexes Induce Apoptosis in Tumor Cells Cancer Res., December 15, 2006; 66(24): 11808 - 11816. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Laud, A. S. Multani, S. M. Bailey, L. Wu, J. Ma, C. Kingsley, M. Lebel, S. Pathak, R. A. DePinho, and S. Chang Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway Genes & Dev., November 1, 2005; 19(21): 2560 - 2570. [Abstract] [Full Text] [PDF] |
||||



